In addition to the loss of SDHB expression, we also found that larger tumor size, extra-adrenal location, noradrenergic phenotype, and earlier age at diagnosis were significantly associated with shorter DFS in PCC/PGL, in agreement with previous findings (14, 15, 38). Here, SDHB is linked to neoplasm.